Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A MacDiarmid

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
International Journal of Clinical Practice|July 14, 2020
Taking OAB seriously: A qualitative evaluation of primary care education on overactive bladder syndrome managementWendy Turell, Alexandra Howson, Scott A MacDiarmid, et al.
The Journal of Urology|August 1, 1995
Management of spinal cord injured patients by indwelling suprapubic catheterizationS A MacDiarmid, E P Arnold, N B Palmer, et al.
The Journal of Urology|September 1, 1992
111Indium-oxine-labeled leukocytes and 67gallium-citrate as indicators of renal injury following extracorporeal shock wave lithotripsyR W Norman, G J Butler, S A MacDiarmid, et al.
The Journal of Urology|September 8, 2005
Efficacy and safety of extended release oxybutynin for the treatment of urge incontinence: an analysis of data from 3 flexible dosing studiesScott A MacDiarmid, Rodney U Anderson, Robert B Armstrong, et al.
BJU International|April 22, 1999
A comparison of ambulatory and conventional urodynamic studies in men with borderline outlet obstructionD J Rosario, S A MacDiarmid, S C Radley, et al.
Open Access Journal of Urology|November 8, 2013
Effect of baseline symptom severity on continence improvement mediated by oxybutynin chloride topical gelPeter K Sand, Scott A Macdiarmid, Heather Thomas, et al.
European Journal of Clinical Pharmacology|November 17, 2009
The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosingBimal K Malhotra, Penelope H Crownover, Robert LaBadie, et al.
Cell Cycle (Georgetown, Tex.)|September 6, 2007
Bacterially-derived nanocells for tumor-targeted delivery of chemotherapeutics and cell cycle inhibitorsJennifer A MacDiarmid, Jocelyn Madrid-Weiss, Nancy B Amaro-Mugridge, et al.
The Journal of Urology|June 1, 1993
Urological dysfunction in patients with diastematomyeliaL M Pérez, N Barnes, S A MacDiarmid, et al.
International Journal for Parasitology|December 1, 1995
Use of a monoclonal antibody to ovine IgE for fly strike studies in sheepJ A MacDiarmid, R Clarke, S J McClure, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
International Journal of Clinical Practice|July 14, 2020
Taking OAB seriously: A qualitative evaluation of primary care education on overactive bladder syndrome managementWendy Turell, Alexandra Howson, Scott A MacDiarmid, et al.
The Journal of Urology|August 1, 1995
Management of spinal cord injured patients by indwelling suprapubic catheterizationS A MacDiarmid, E P Arnold, N B Palmer, et al.
The Journal of Urology|September 1, 1992
111Indium-oxine-labeled leukocytes and 67gallium-citrate as indicators of renal injury following extracorporeal shock wave lithotripsyR W Norman, G J Butler, S A MacDiarmid, et al.
The Journal of Urology|September 8, 2005
Efficacy and safety of extended release oxybutynin for the treatment of urge incontinence: an analysis of data from 3 flexible dosing studiesScott A MacDiarmid, Rodney U Anderson, Robert B Armstrong, et al.
BJU International|April 22, 1999
A comparison of ambulatory and conventional urodynamic studies in men with borderline outlet obstructionD J Rosario, S A MacDiarmid, S C Radley, et al.
Open Access Journal of Urology|November 8, 2013
Effect of baseline symptom severity on continence improvement mediated by oxybutynin chloride topical gelPeter K Sand, Scott A Macdiarmid, Heather Thomas, et al.
European Journal of Clinical Pharmacology|November 17, 2009
The pharmacokinetic profile of fesoterodine 8 mg with daytime or nighttime dosingBimal K Malhotra, Penelope H Crownover, Robert LaBadie, et al.
Cell Cycle (Georgetown, Tex.)|September 6, 2007
Bacterially-derived nanocells for tumor-targeted delivery of chemotherapeutics and cell cycle inhibitorsJennifer A MacDiarmid, Jocelyn Madrid-Weiss, Nancy B Amaro-Mugridge, et al.
The Journal of Urology|June 1, 1993
Urological dysfunction in patients with diastematomyeliaL M Pérez, N Barnes, S A MacDiarmid, et al.
International Journal for Parasitology|December 1, 1995
Use of a monoclonal antibody to ovine IgE for fly strike studies in sheepJ A MacDiarmid, R Clarke, S J McClure, et al.
Pageof 8